Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
CAN, UNFI, SUNB, More
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $85.4 million versus the consensus estimate of $81.62 million.
GUIDANCE:
Catalyst Pharmaceuticals sees FY2023 revenue of $195-205 million, versus the consensus of $165.8 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
